Entity Type
Individual
Filer Snapshot
Thomas Garner
CIK 0001996325. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total Filings
6
Latest Filing
10 Mar 2026
Industry
n/a
Follow future filing-backed changes
Save this filer to return when a new filing changes the portfolio, large-stake, insider, or company context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Best next click
Start with the summary below, then verify the strongest source-backed page for this filer.
- Open 13F if you want portfolio holdings.
- Open 13D/G or insider pages only when this CIK has those rows.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 10 Mar 2026 for CIK 0001996325.
- Business address
- C/O Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA, 92130
- Top holdings (ownership)
- ACAD and LXRX
Filer intelligence
What SEC filings say about Thomas Garner
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
Quick read
- Forms 3/4/5 show insider context for ACAD worth $762.7K.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
Forms 3/4/5 insider context
ACAD
06 Mar 2026 · EVP, Chief Commercial Officer
LXRX
08 Feb 2024 · SVP, Chief Commercial Officer
Latest update
What changed recently for Thomas Garner
Latest ownership report period: 06 Mar 2026. Open the source-backed page to inspect the fresh filing or facts context.
Update date
10 Mar 2026
Page type
Ownership filings
Latest period
06 Mar 2026
Ownership context was refreshed from SEC Forms 3/4/5 filed on 10 Mar 2026.
Filer Overview
Thomas Garner has filed 6 SEC EDGAR filings since 11 Oct 2023. Common forms include 4, 3.
Latest Filings
Recent SEC filings for Thomas Garner with direct links to document and filing folders.
4
File 000-50768
4 filing
- Filing date
- 10 Mar 2026
- Reporting date
- 06 Mar 2026
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 000-50768
4 filing
- Filing date
- 10 Dec 2024
- Reporting date
- 09 Dec 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
File 000-50768
3 filing
- Filing date
- 10 Dec 2024
- Reporting date
- 09 Dec 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 000-30111
PRIMARY DOCUMENT
- Filing date
- 12 Feb 2024
- Reporting date
- 08 Feb 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
File 000-30111
PRIMARY DOCUMENT
- Filing date
- 11 Oct 2023
- Reporting date
- 09 Oct 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
3
File 000-30111
PRIMARY DOCUMENT
- Filing date
- 11 Oct 2023
- Reporting date
- 09 Oct 2023
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
About this filer
Thomas Garner files with the SEC under CIK 0001996325. This page aggregates EDGAR filings and related ownership activity.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.